Decreased levels of plasma adiponectin in prediabetes, Type 2 Diabetes and coronary artery disease

Medical Science Monitor

Volumn 12, Issue 1, 2006, Pages

  Yaturu, Subhashini ^a,b   Bridges, Juanita ^a   Reddy, Dhani Reddy Rama Subba ^b  

^a OVERTON BROOKS VA MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adiponectin; Coronary artery disease; Impaired fasting glucose; Insulin resistance; Prediabetes; Type 2 Diabetes

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; HORMONE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; AGED; BLOOD GLUCOSE; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; PREDIABETIC STATE;

EID: 30944434223     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mokdad AH, Bowman BA, Ford ES et al: The continuing epidemics of obesity and diabetes in the United States. Jama, 2001; 286: 1195-200
2. Dinneen SF, Maldonado D III, Leibson CL et al: Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care, 1998; 21: 1408-13
3. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes, 2003; 52: 1210-14
4. Scherer PE, Williams S, Fogliano M et al: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995; 270: 26746-49
5. Arita Y, Kihara S, Ouchi N et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999; 257: 79-83
6. Asayama K, Hayashibe H, Dobashi K et al: Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res, 2003; 11: 1072-79
7. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002; 87: 2764-69
8. Hotta K, Funahashi T, Arita Y et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000; 20: 1595-99
9. Pellme F, Smith U, Funahashi T et al: Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes, 2003; 52: 1182-86
10. Weyer C, Funahashi T, Tanaka S et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001; 86: 1930-35
11. Engeli S, Feldpausch M, Gorzelniak K et al: Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003; 52: 942-47
12. Bełtowski J: Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit, 2003; 9(2): RA55-RA61
13. Yamauchi T, Kamon J, Waki H et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001; 7: 941-46
14. Halleux CM, Takahashi M, Delporte ML et al: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun, 2001; 288: 1102-7
15. Costacou T, Zgibor JC, Evans RW et al: The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia, 2005; 48: 41-48
16. Nakamura Y, Shimada K, Fukuda D et al: Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart, 2004; 90: 528-33
17. Miyazaki T, Shimada K, Mokuno H, Daida H: Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart, 2003; 89: 663
18. Dzielinska Z, Januszewicz A, Wiecek A et al: Decreased plasma concentration of a novel anti-inflammatory protein - adiponectin - in hypertensive men with coronary artery disease. Thromb Res, 2003; 110: 365-69
19. Snehalatha C, Mukesh B, Simon M et al: Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care, 2003; 26: 3226-29
20. Maeda K, Ishihara K, Miyake K et al: Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes. Metabolism, 2005; 54: 775-80
21. Kim MJ, Yoo KH, Park HS et al: Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J, 2005; 46: 42-50
22. Shetty GK, Economides PA, Horton ES et al: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 2004; 27: 2450-57
23. Osei K, Gaillard T, Kaplow J et al: Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism, 2004; 53: 1552-57
24. Osei K, Gaillard T, Schuster D: Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res, 2005; 13: 179-85
25. Chan KC, Chou HH, Wu DJ et al: Diabetes mellitus has an additional effect on coronary artery disease. Jpn Heart J, 2004; 45: 921-27
26. Kopp HP, Krzyzanowska K, Mohlig M et al: Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes Relat Metab Disord, 2005; 29: 766-71